A
$ Value
$0
Shares
3,673
Price
$0
Filed
Oct 2
Insider
Name
LEUNG SANDRA
Title
—
CIK
0001199294
Roles
Director
Transaction Details
Transaction Date
2025-09-30
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
33,822
Footnotes
Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending September 30, 2025, each representing a contingent right to receive one common share, no par value, of the Issuer.
Filing Info
LEUNG SANDRA's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-31 | BHC | A | $32K |
| 2025-12-31 | BHC | A | $0 |
| 2025-09-30 | BHC | A | $0 |
| 2025-07-25 | BHC | A | $0 |
Other Insiders at BHC (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| LEUNG SANDRA | — | — | 2026-03-31 |
| Paulson John | — | — | 2026-03-31 |
| WECHSLER AMY B | — | — | 2026-03-31 |
|
APPIO THOMAS
Chief Executive Officer
|
— | — | 2026-03-02 |
|
Charhon Jean-Jacques
EVP, CFO
|
— | — | 2026-02-27 |
|
LEE STEVEN HYOSIG
SVP, Controller & CAO
|
— | — | 2026-02-25 |
|
Carson Seana
EVP, General Counsel
|
— | $115K | 2026-03-03 |
|
Lenar Aimee J.
EVP, US Pharma
|
— | — | 2026-02-26 |